Genetic profile of astrocytic and oligodendroglial gliomas
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2011/03/26
-
Journal
-
Indian UGC (journal)
-
Refrences30
-
Citations112
-
Hiroko Ohgaki
-
Paul Kleihues
Cite
Ohgaki, Hiroko, and Paul Kleihues. “Genetic Profile of Astrocytic and Oligodendroglial Gliomas”. Brain Tumor Pathology, vol. 28, no. 3, 2011, pp. 177-83, https://doi.org/10.1007/s10014-011-0029-1.
Ohgaki, H., & Kleihues, P. (2011). Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathology, 28(3), 177-183. https://doi.org/10.1007/s10014-011-0029-1
Ohgaki, Hiroko, and Paul Kleihues. “Genetic Profile of Astrocytic and Oligodendroglial Gliomas”. Brain Tumor Pathology 28, no. 3 (2011): 177-83. https://doi.org/10.1007/s10014-011-0029-1.
Ohgaki H, Kleihues P. Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathology. 2011;28(3):177-83.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
Medicine
Pathology
You May Also Like
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
- Ischemic rat brain extracts induce human marrow stromal cell growth factor production
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Molecular signatures classify astrocytic gliomas by IDH1 mutation status | International Journal of Cancer |
| 61 | 2011 |
| DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma | CancerSpectrum Knowledge Environment |
| 189 | 2011 |
| 10.2353/ajpath.2010.100680 | The American Journal of Pathology |
| 2010 | |
| Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing | Acta Neuropathologica |
| 97 | 2010 |
| The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma | Acta Neuropathologica |
| 224 | 2010 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 19
is the most frequently represented among the references in this article. It primarily includes studies from Acta Neuropathologica and The American Journal of Pathology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target | Medical Oncology |
| 2 | 2023 |
Prediction of Tumor Development and Urine-Based Liquid Biopsy for Molecule-Targeted Therapy of Gliomas | Genes |
| 2023 | |
The STAT3-Regulated Autophagy Pathway in Glioblastoma | Pharmaceuticals |
| 3 | 2023 |
| Multi-omics data integration for subtype identification of Chinese lower-grade gliomas: A joint similarity network fusion approach | Computational and Structural Biotechnology Journal |
| 1 | 2022 |
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas | Neuro-Oncology |
| 19 | 2022 |
Citations Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 45
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Emerging Variant Glioma: Glioblastoma with a Primitive Neuro-Ectodermal Tumor(PNET) Component and was published in 1970. The most recent citation comes from a 2023 study titled Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. This article reached its peak citation in 2013, with 22 citations. It has been cited in 78 different journals, 23% of which are open access. Among related journals, the Neuro-Oncology cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.